CHRM1 and neoplasm: Simultaneously, differentiation- and immune-activating signals such as CSF1, TNFSF9, KITLG, EHF, and CHRM1 were downregulated, potentially modulating tumor immune escape and proliferation in a context-dependent manner [47].